Tagged with South Africa

The Oxford R21 Malaria Vaccine and the Imperative of Continued Malaria Testing
Aspen Looks to African Vaccine Manufacturing to Secure Future Access
Six Factors Behind the Evolution of MEA’s Pharma Market
South Africa Pharma News: Afrigen’s partnership with US NIH, BioNTech’s Efforts to Bring mRNA Manufacturing to Africa and Ascendis Health’s Deal with Austell Pharmaceuticals for its Pharma Division
MEA Pharma Market to Reach USD 47 billion in 2022; Gilead’s Sales Skyrocketing
Africa’s Renewed Hope for Drug Discovery and Health Innovation
South Africa Pharma News: Vaccines Made in Africa to Stay in Africa; Aspen Profits Up 21%; Adcock Ingram’s Down 3%
Africa’s Biggest Pharma Company Gets $700 million for Vaccine Manufacturing Know-How
South Africa Pharma News: Ramaphosa Slams Big Pharma; Aspen Gets $700M for Vaccine Know-How; Adcock Ingram Takes Big COVID Profit Hit
The COVID-19 Vaccine Rush: Nationalism, Access & IP Issues
South Africa’s Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
Malaria Prevention Cannot be Allowed to Stall During the COVID-19 Pandemic
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here